The ability of three different 'physical' drug delivery systems: liposomes, niosomes and starch microparticles, to increase the efficacy of sodium stibogluconate in clearing L. donovani from the liver of mice have been characterised. The efficacy of free sodium stibogluconate in this model has been used as the standard against which to measure the effectiveness of the drug delivery systems. The two vesicular systems; liposomes and niosomes, gave an approximate ten-fold increase in efficacy compared with the free drug. Modifying the properties of the vesicles by varying their cholesterol content and hence their permeability to the encapsulated drug or varying their surface charge by the inclusion of dicetyl phosphate appeared to have little ...
Although three new drugs or drug formulations, liposomal amphotericin B (AmBisome), miltefosine and ...
AbstractLeishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
The ability of three different 'physical' drug delivery systems: liposomes, niosomes and starch micr...
Leishmaniasis is a disease caused by infection with the protozoan parasite Leishmania, which is resp...
The hypothesis that compounds that inhibit the synthesis or interfere with the activity of trypanoth...
Leishmania, a protozoan parasite, is responsible for a group of diseases known as leishmaniases (Ros...
Co-treatment of mice infected with different strains of Leishmania donovani with a non-ionic surfact...
SummaryAbout 1.5 million new cases of cutaneous leishmaniasis and 500 000 new cases of visceral leis...
AbstractBackgroundLeishmaniasis is one of the neglected diseases included in the World Health Organi...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
AbstractThe efficacy of sodium stibogluconate against Leishmania donovani infections was markedly en...
The Leishmaniases are parasitic diseases caused by intracellular infectious agents – the kinetoplast...
Background. Leishmaniases (VL) represents a major health problem. The first part of the thesis eval...
Although three new drugs or drug formulations, liposomal amphotericin B (AmBisome), miltefosine and ...
AbstractLeishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...
Background: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment o...
The ability of three different 'physical' drug delivery systems: liposomes, niosomes and starch micr...
Leishmaniasis is a disease caused by infection with the protozoan parasite Leishmania, which is resp...
The hypothesis that compounds that inhibit the synthesis or interfere with the activity of trypanoth...
Leishmania, a protozoan parasite, is responsible for a group of diseases known as leishmaniases (Ros...
Co-treatment of mice infected with different strains of Leishmania donovani with a non-ionic surfact...
SummaryAbout 1.5 million new cases of cutaneous leishmaniasis and 500 000 new cases of visceral leis...
AbstractBackgroundLeishmaniasis is one of the neglected diseases included in the World Health Organi...
The efficacy of sodium stibogluconate against Leishmania donovani infections was markedly enhanced b...
AbstractThe efficacy of sodium stibogluconate against Leishmania donovani infections was markedly en...
The Leishmaniases are parasitic diseases caused by intracellular infectious agents – the kinetoplast...
Background. Leishmaniases (VL) represents a major health problem. The first part of the thesis eval...
Although three new drugs or drug formulations, liposomal amphotericin B (AmBisome), miltefosine and ...
AbstractLeishmaniasis is a parasitic disease caused by the intramacrophage protozoa Leishmania spp. ...
Fungisome® (F), a liposomal amphotericin B (AmB) product, is marketed in India as a safe and effecti...